New eye test may spot vision loss early in brain pressure disorder
NCT ID NCT03304314
First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 34 times
Summary
This study is testing a new, non-invasive eye test called pupillometry to see if it can detect vision problems in people with pseudotumor cerebri (a condition where pressure builds up in the skull). Researchers will measure how the pupils react to colored lights in 50 patients and 50 healthy volunteers. The goal is to find a faster, easier way to check for vision loss without requiring much effort from the patient.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSEUDOTUMOR CEREBRI are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sheba Medical Center
RECRUITINGTel Litwinsky, 52621, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.